Birdwatch Note Rating
2023-05-20 23:27:17 UTC - NOT_HELPFUL
Rated by Participant: 244D1FE2B12F38B2FD07A54020EC5AAEF22FD56964ED1BF38AE68770D03D006D
Participant Details
Original Note:
A phase three trial found Pfizer’s shot was nearly 82% effective at preventing severe disease from RSV in newborns during the first 90 days of life. RSV is a leading cause of hospitalization in children <1 year of age. https://pubmed.ncbi.nlm.nih.gov/23878043/ https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-positive-top-line-data-phase-3-global
All Note Details